BackBelite Bio Overview

Belite Bio Total Current Liabilities

Latest total current liabilities for BLTE: $15M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$14.95M
↑ 129.16% YoYΔ $8.42M vs prior year quarter

Peer trimmed avg / median

Loading

Belite Bio Total Current Liabilities History

Loading

Belite Bio vs. peers: Total Current Liabilities Comparison

Loading

Belite Bio Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Belite Bio (BLTE) FAQ

As of the most recent data (June 2026), BLTE shows a total current liabilities of $15M. That compares with $6.5M in the prior-year period — up 129.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLTE's total current liabilities is now $15M (was $6.5M) — a 129.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Belite Bio is outperforming or lagging.

Tracking BLTE's total current liabilities over time shows whether Belite Bio is scaling, shrinking, or reshaping that part of the business. The current reading is $15M That compares with $6.5M in the prior-year period — up 129.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Belite Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $15M) with ownership activity and broader fundamentals.